Circulating tumour DNA dynamics predict recurrence in stage III melanoma patients receiving neoadjuvant immunotherapyWei Yen Chan, Helen Rizos, Christian U. Blank et al.|Journal of Experimental & Clinical Cancer Research|2024Cited by 22
Use of early circulating tumour DNA dynamics in patients with stage III melanoma receiving neoadjuvant combination immunotherapy.Wei Yen Chan, Helen Rizos, Jenny Lee et al.|Journal of Clinical Oncology|2024Cited by 2
Abstract 731: Integrating ctDNA and FDG-PET dynamics to predict pathological response following neoadjuvant systemic therapy in stage III melanomaWei Yen Chan, Helen Rizos, Georgina V. Long et al.|Cancer Research|2025Cited by 0